公开(公告)号：HK1092135A1

公开(公告)日：2007-02-02

申请号：HK06108741

申请日：2006-08-07

Applicant: ABBOTT LAB

Inventor： BUCKLEY MICHAEL J ,  JI JIANGUO

IPC: A61K20060101 ,  A61P20060101 ,  A61P29/00 ,  C07D20060101 ,  C07D487/04

Abstract: The present invention discloses (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane and its use to treat pain and other disorders associated with the nicotinic acetylcholine receptor.

公开(公告)号：CA2573688A1

公开(公告)日：2006-02-23

申请号：CA2573688

申请日：2005-07-08

Applicant: ABBOTT LAB

Inventor： HANNICK STEVEN M ,  HENRY RODGER F ,  ROBBINS TIMOTHY A ,  WAYNE GREG S ,  WITTENBERGER STEVEN J ,  WANG WEILI W ,  LI WENKE ,  TOWNE TIMOTHY B ,  MARCI BRYAN S ,  BUCKLEY MICHAEL J ,  KOTECKI BRIAN J ,  ZHANG GEOFF G ,  JI JIANGUO

IPC: C07D487/04 ,  A61K31/4439

Abstract: The present invention discloses (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane, salts thereof, and its use to treat pain and other disorders associated with the nicotinic acetylcholine receptor.